Detalhe da pesquisa
1.
Human fetal cerebellar cell atlas informs medulloblastoma origin and oncogenesis.
Nature
; 612(7941): 787-794, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36450980
2.
Use of gemcitabine, oxaliplatin, and anti-CD20 therapy in children and adolescents with non-Hodgkin lymphoma unfit for intensive therapy.
Pediatr Blood Cancer
; 70(4): e30214, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36694431
3.
Barriers to medication adherence among adolescents and young adults with cancer.
Pediatr Blood Cancer
; 70(3): e30186, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36602026
4.
Data standards in pediatric oncology: Past, present, and future.
Pediatr Blood Cancer
; 70(2): e30128, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36495256
5.
Treatment of posttransplant lymphoproliferative disorder with poor prognostic features in children and young adults: Short-course EPOCH regimens are safe and effective.
Pediatr Blood Cancer
; 68(8): e29126, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34019326
6.
Visual outcomes following everolimus targeted therapy for neurofibromatosis type 1-associated optic pathway gliomas in children.
Pediatr Blood Cancer
; 68(4): e28833, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33336845
7.
Use of CD19-directed CAR T-Cell Therapy in an Infant With Refractory Acute Lymphoblastic Leukemia.
J Pediatr Hematol Oncol
; 43(4): 152-154, 2021 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32496443
8.
Viral surveillance using PCR during treatment of AML and ALL.
Pediatr Blood Cancer
; 65(1)2018 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-28792686
9.
Population pharmacokinetics of temsirolimus and sirolimus in children with recurrent solid tumours: a report from the Children's Oncology Group.
Br J Clin Pharmacol
; 83(5): 1097-1107, 2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28000286
10.
US News & World Report and quality metrics: Inclusion of sickle cell disease is a matter of equity.
Pediatr Blood Cancer
; 69(8): e29679, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35441787
11.
A phase 1 study of the c-Met inhibitor, tivantinib (ARQ197) in children with relapsed or refractory solid tumors: A Children's Oncology Group study phase 1 and pilot consortium trial (ADVL1111).
Pediatr Blood Cancer
; 64(11)2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-28449393
12.
Pilot study of intravenous melphalan combined with continuous infusion L-S,R-buthionine sulfoximine for children with recurrent neuroblastoma.
Pediatr Blood Cancer
; 62(10): 1739-46, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26153194
13.
AAML0523: a report from the Children's Oncology Group on the efficacy of clofarabine in combination with cytarabine in pediatric patients with recurrent acute myeloid leukemia.
Cancer
; 120(16): 2482-9, 2014 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24771494
14.
Vav3 collaborates with p190-BCR-ABL in lymphoid progenitor leukemogenesis, proliferation, and survival.
Blood
; 120(4): 800-11, 2012 Jul 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-22692505
15.
A phase I trial of MK-2206 in children with refractory malignancies: a Children's Oncology Group study.
Pediatr Blood Cancer
; 61(7): 1246-51, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24664955
16.
A Phase 2 study of bortezomib combined with either idarubicin/cytarabine or cytarabine/etoposide in children with relapsed, refractory or secondary acute myeloid leukemia: a report from the Children's Oncology Group.
Pediatr Blood Cancer
; 61(10): 1754-60, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-24976003
17.
Low dose decitabine in very high risk relapsed or refractory acute myeloid leukaemia in children and young adults.
Br J Haematol
; 161(3): 406-10, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23432727
18.
Children's Oncology Group's 2013 blueprint for research: acute myeloid leukemia.
Pediatr Blood Cancer
; 60(6): 964-71, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23255301
19.
Ultra-high dose-rate proton FLASH improves tumor control.
Radiother Oncol
; 186: 109741, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37315577
20.
Proton FLASH Radiotherapy for the Treatment of Symptomatic Bone Metastases: The FAST-01 Nonrandomized Trial.
JAMA Oncol
; 9(1): 62-69, 2023 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36273324